Skip to main content
. 2020 Aug 19;10:1277. doi: 10.3389/fonc.2020.01277

Table 1.

Clinical features of the patient-derived xenograft (PDX) utilized in this study.

Sample ID Histotype Stage Grade Diagnosis/relapse
PDOVCA 14 Endometrioid 3C G1 Diagnosis
PDOVCA 15 Serous-papillary 4 G3 Relapse
PDOVCA 17 Serous-papillary 3C G3 Diagnosis
PDOVCA 24 Serous-papillary 3A G3 Relapse
PDOVCA 36 Serous 4 G3 Relapse
PDOVCA 39 Serous-papillary 3B G2 Relapse
PDOVCA 44 Serous-papillary 3C G3 Diagnosis
PDOVCA 49 Serous-papillary 3A G1 Relapse
PDOVCA 52 Serous-papillary 3C G3 Diagnosis
PDOVCA 53 Endometrioid 3C G3 Relapse
PDOVCA 54 Serous-papillary 4 G1 Relapse
PDOVCA 57 Serous-papillary 3C G3 Relapse
PDOVCA 58 Serous-papillary 3A G3 Relapse
PDOVCA 62 Serous-papillary 3C G3 Relapse
PDOVCA 69 Serous-papillary 3C G3 Relapse
PDOVCA 70 Serous-papillary 3C G3 Relapse
PDOVCA 82 Serous-papillary 3C G3 Relapse

Histotype, stage, and grade refer to the patient samples from whom PDXs were derived. Diagnosis/relapse indicates that PDXs were established from ascitic fluid samples obtained at diagnosis or relapse, respectively.